Novartis melanoma combo wins key thumbs-up from cost watchdog NICE after Opdivo shut outAllbiopro2018-09-19T00:53:04+09:009월 19th, 2018|
Johnson & Johnson’s talc supplier inks 11th-hour settlement in California mesothelioma case: reportAllbiopro2018-09-19T00:52:35+09:009월 19th, 2018|
Novartis revamps bonus pay as ethics rise to top priority at scandal-hit drugmakerAllbiopro2018-09-19T00:52:05+09:009월 19th, 2018|
Scientists weigh Zika vaccine challenge study after case count plummets: reportAllbiopro2018-09-19T00:51:36+09:009월 19th, 2018|
Pfizer ‘all in’ on advancing next-generation pneumococcal vaccine candidate: CFOAllbiopro2018-09-19T00:51:08+09:009월 19th, 2018|
Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production; Merck not as luckyAllbiopro2018-09-19T00:50:40+09:009월 19th, 2018|
With latest data, can AstraZeneca’s COPD triple combo rival Glaxo’s Trelegy?Allbiopro2018-09-19T00:50:10+09:009월 19th, 2018|
Sanofi, Regeneron pad Dupixent’s case in adolescent eczema ahead of key asthma decisionAllbiopro2018-09-19T00:49:41+09:009월 19th, 2018|
Novo to lay off 400 staff in major R&D reorganizationAllbiopro2018-09-19T00:49:13+09:009월 19th, 2018|
Viking Therapeutics’ fatty liver med cuts cholesterol in phase 2Allbiopro2018-09-19T00:48:18+09:009월 19th, 2018|
Roivant launches lung-focused Respivant with phase 2 IPF drugAllbiopro2018-09-19T00:47:25+09:009월 19th, 2018|
Allergan, Sosei halt Alzheimer’s trials amid safety scareAllbiopro2018-09-19T00:46:57+09:009월 19th, 2018|
Virion Biotherapeutics fills out executive ranks with CEO, CSOAllbiopro2018-09-19T00:46:30+09:009월 19th, 2018|
Servier drops GeNeuro’s multiple sclerosis drug after midphase missAllbiopro2018-09-19T00:46:02+09:009월 19th, 2018|
CRISPR Therapeutics, ViaCyte team up on gene-edited diabetes treatmentAllbiopro2018-09-19T00:45:34+09:009월 19th, 2018|
Genentech antibiotic shows broad activity against multidrug-resistant bugs in miceAllbiopro2018-09-19T00:45:06+09:009월 19th, 2018|
